0001415889-24-002873.txt : 20240206
0001415889-24-002873.hdr.sgml : 20240206
20240206214710
ACCESSION NUMBER: 0001415889-24-002873
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240202
FILED AS OF DATE: 20240206
DATE AS OF CHANGE: 20240206
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Coen Stacy Ann
CENTRAL INDEX KEY: 0001814150
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-17999
FILM NUMBER: 24601930
MAIL ADDRESS:
STREET 1: 11 RUSH POND RD
CITY: LAKEVILLE
STATE: MA
ZIP: 02347
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ImmunoGen, Inc.
CENTRAL INDEX KEY: 0000855654
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 042726691
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 830 WINTER ST
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: (781)895-0600
MAIL ADDRESS:
STREET 1: 830 WINTER ST
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: IMMUNOGEN INC
DATE OF NAME CHANGE: 19920703
4
1
form4-02072024_020202.xml
X0508
4
2024-02-02
0000855654
ImmunoGen, Inc.
IMGN
0001814150
Coen Stacy Ann
C/O IMMUNOGEN, INC.
830 WINTER STREET
WALTHAM
MA
02451
false
true
false
false
SVP & CHIEF BUSINESS OFFICER
1
Common Stock
2024-02-02
4
M
0
14350
0
A
77857
D
Common Stock
2024-02-05
4
S
0
4583
29.30
D
73274
D
Restricted Stock Unit
0
2024-02-02
4
M
0
14350
0
D
Common Stock
14350
28700
D
Effected pursuant to a trading plan adopted on June 15, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.
The RSUs were awarded on 2/3/2023 and vest over a three-year period, with 33 1/3% of the RSUs vesting on each of the first three anniversaries of the date of grant, subject to continued service through each vesting date.
/s/ Renee Lentini, Attorney-in-Fact
2024-02-06